Price
No data yet.
Social Signal Score
Analyst Ratings
7 analystsRevenue
$297.98M+338.35%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Brent J. Guerisoli
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 9,700
- Beta
- 1.27
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.71
Financials
Revenue
$297.98M+338.3%Net Income
$9.08M+168.6%EBITDA
$19.30M+265.9%Free Cash Flow
$10.22M+627.2%EPS (diluted)
$0.25+106.6%Shares Outstanding (diluted)
35.96M+28.4%Operating Expenses
$21.61MCash & Debt
$15.27MReturn of Capital
$0.00Revenue by Segment (annual)
$946.37MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $947.71M | $29.58M | $0.86 |
| 2024 | $695.24M | $22.56M | $0.72 |
| 2023 | $544.89M | $13.38M | $0.45 |
| 2022 | $473.24M | $6.64M | $0.23 |
| 2021 | $439.69M | $2.70M | $0.08 |
| 2020 | $390.95M | $15.74M | $0.56 |
| 2019 | $338.53M | $2.55M | $0.09 |
| 2018 | $286.06M | $15.68M | $0.56 |
| 2017 | $250.99M | $9.87M | $0.35 |
| 2016 | $217.22M | $7.89M | $0.28 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from PNTG's reported EPS growth of 13.3% a year over 9 years.
- EPS in 5 years
- $1.60
- Implied price
- $52.73
- Return from $39.82
- 5.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $26.21 — -34.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 23 | 28 | 33 | 38 | 43 |
|---|---|---|---|---|---|
| 3.3% | -10.3% | -6.7% | -3.6% | -0.8% | 1.7% |
| 8.3% | -5.9% | -2.2% | 1.1% | 4.0% | 6.6% |
| 13.3% | -1.6% | 2.4% | 5.8% | 8.8% | 11.5% |
| 18.3% | 2.8% | 6.9% | 10.4% | 13.6% | 16.4% |
| 23.3% | 7.1% | 11.4% | 15.1% | 18.4% | 21.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
127+26.67%Social Signal Score
Mentions (2)
- Newszacks.com·5h ago·Positive
All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy The Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newsglobenewswire.com·13d ago·Neutral
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.
View source ↗
Earnings
Wed, Nov 4(in 7 weeks)
Consensus estimate $0.33 per share
Typical surprise +3.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$0.36 vs $0.33beat
- Wed, May 6$0.32 vs $0.31beat
- Wed, Feb 25$0.34 vs $0.31beat
- Wed, Nov 5$0.30 vs $0.29beat
- Wed, Aug 6$0.27 vs $0.26beat
- Tue, May 6$0.27 vs $0.22beat
Estimates and results for PNTG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by PNTG officers and directors.
- Bought
- —
- Sold
- $968k
0 trades
13 trades
- Cheney Kirk Sterlingsold
- Guerisoli Brentsold
- Steik Jason Paulsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
- Guerisoli Brentsold
87 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in PNTG.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.